There is an obvious question behind OAM Medical Ventures: why would a group rooted in clinical operations and hospitality start writing cheques for software? The honest answer is that we have watched the gap from the inside.
We have lived the bottleneck
Our team has built and run medical technology at Philips and GE Healthcare. We know where care slows down, where diagnoses are missed, and where good clinicians are overwhelmed by volume. Most of those problems are now addressable with AI — and most are still unaddressed in this region.
We are not investing in AI because it is fashionable. We are investing because we know exactly what it can fix.
Capital with context
A cheque is the easy part. What founders in medicine actually need is regulatory familiarity, clinical sites to validate in, and a route to market. We bring all three, plus the balance sheet of the OM Group — so the right team can move from pilot to deployment without starting from zero.
That is the thesis in one line: operators who understand the problem, funding the people who can solve it.